| Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12 AK Singh, RK Arya, AK Trivedi, S Sanyal, R Baral, O Dormond, ... Cytokine & growth factor reviews 24 (1), 41-49, 2013 | 222 | 2013 |
| The role of poly ADP-ribosylation in the first wave of DNA damage response C Liu, A Vyas, MA Kassab, AK Singh, X Yu Nucleic acids research 45 (14), 8129-8141, 2017 | 207 | 2017 |
| Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance AK Singh, RK Arya, S Maheshwari, A Singh, S Meena, P Pandey, ... International journal of cancer 136 (9), 1991-2000, 2015 | 141 | 2015 |
| EZH2: not EZHY (easy) to deal G Deb, AK Singh, S Gupta Molecular cancer research 12 (5), 639-653, 2014 | 120 | 2014 |
| Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells SS Chauhan, AK Singh, S Meena, M Lohani, A Singh, RK Arya, ... Bioorganic & medicinal chemistry letters 24 (13), 2820-2824, 2014 | 74 | 2014 |
| Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis RK Arya, A Singh, NK Yadav, SH Cheruvu, Z Hossain, S Meena, ... Scientific reports 5 (1), 18457, 2015 | 60 | 2015 |
| Selective targeting of TET catalytic domain promotes somatic cell reprogramming AK Singh, B Zhao, X Liu, X Wang, H Li, H Qin, X Wu, Y Ma, D Horne, X Yu Proceedings of the National Academy of Sciences 117 (7), 3621-3626, 2020 | 51 | 2020 |
| Thioaryl naphthylmethanone oxime ether analogs as novel anticancer agents B Chakravarti, T Akhtar, B Rai, M Yadav, J Akhtar Siddiqui, ... Journal of Medicinal Chemistry 57 (19), 8010-8025, 2014 | 44 | 2014 |
| Poly (ADP-ribosyl) ation mediates early phase histone eviction at DNA lesions G Yang, Y Chen, J Wu, SH Chen, X Liu, AK Singh, X Yu Nucleic Acids Research 48 (6), 3001-3013, 2020 | 35 | 2020 |
| EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis A Verma, A Singh, MP Singh, MA Nengroo, KK Saini, SR Satrusal, ... Nature Communications 13 (1), 7344, 2022 | 34 | 2022 |
| Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer AK Singh, SS Chauhan, SK Singh, VV Verma, A Singh, RK Arya, ... Carcinogenesis 37 (11), 1027-1040, 2016 | 22 | 2016 |
| Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells AK Singh, A Verma, A Singh, RK Arya, S Maheshwari, P Chaturvedi, ... Epigenetics 16 (2), 144-161, 2021 | 21 | 2021 |
| CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5 MA Nengroo, S Maheshwari, A Singh, A Verma, RK Arya, P Chaturvedi, ... Cell Death & Disease 12 (5), 464, 2021 | 20 | 2021 |
| Discovery of a novel small-molecule inhibitor that targets PP2A–β-catenin signaling and restricts tumor growth and metastasis S Maheshwari, SR Avula, A Singh, LR Singh, GR Palnati, RK Arya, ... Molecular Cancer Therapeutics 16 (9), 1791-1805, 2017 | 18 | 2017 |
| Exosomes: emerging players of intercellular communication in tumor microenvironment S Maheshwari, AK Singh, RK Arya, D Pandey, A Singh, D Datta Discoveries 2 (3), 2014 | 17 | 2014 |
| Tissue-specific carcinogens as soil to seed BRCA1/2-mutant hereditary cancers AK Singh, X Yu Trends in Cancer 6 (7), 559-568, 2020 | 16 | 2020 |
| AI26 inhibits the ADP-ribosylhydrolase ARH3 and suppresses DNA damage repair X Liu, R Xie, LY Lily, SH Chen, X Yang, AK Singh, H Li, C Wu, X Yu Journal of Biological Chemistry 295 (40), 13838-13849, 2020 | 7 | 2020 |
| The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops CW Chang, AK Singh, M Li, L Guan, N Le, K Omabe, F Liang, Y Liu Proceedings of the National Academy of Sciences 119 (50), e2217542119, 2022 | 6 | 2022 |
| Novel Therapeutic Targeting of UHRF1 Restores 5'-Azacytidine Response in Resistant Acute Myeloid Leukemia AK Singh, X Yu Blood 132, 1356, 2018 | 3 | 2018 |
| Epigenetic modulator EZH2 governs CSC properties and alters metastatic cascade A Verma, A Singh, AK Singh, P Chaturvedi, MA Nengroo, D Datta Cancer Medicine 7, 30-30, 2018 | 2 | 2018 |
Dipak DattaProfessor, Senior Principal Scientist, CSIR-Central Drug Research InstituteVerified email at cdri.res.in
